Chat with us, powered by LiveChat

Beta Agonist Feed Additives Market

Beta Agonist Feed Additives Market: Segmented: By Product Type (Zilpaterol and Ractopamine), By Animal Type (Cattle, Sheep, Swine, Buffalo, Others), By End Users (Home, Barns, Hoggery, Other), And Region - Global Analysis of Market Size, Share & Trends For 2019-2022 And Forecasts To 2032

Published on: Nov-2022
Report Code: FG F&B 01005
No. of Pages: 170-350
Report Format: PDF

Product Overview

Beta Agonist Feed Additives Market to surpass USD 124.2 billion by 2032 from USD 83.5 billion in 2021 at a CAGR of 3.7% in the coming years, i.e., 2022-2032.

Beta-agonists belong to the category of the non-hormonal compound, fed to cattle. They aim to bind to receptors on the animal body’s fat cells and redirect and lower the fat metabolism. Consequently, less amount of fat is produced and stored in the carcass. Simultaneously, these compounds bind to animal muscle cells and redirect and grow the muscle fiber size. Muscle fiber size substitutes some of the weight that is usually present in fat and the complete carcass comprises a higher amount of lean muscle. These actions considerably lower the energy provided by the feed to weight gain. If the same level of feed intake produces more weight, the efficiency of the feed is increased.

Market Highlights

Global Beta Agonist Feed Additives Market is expected to project a notable CAGR of 3.7% in 2032

Increasing consumption of animal meat per person throughout the world and the increasing use of beta-agonist feed to produce cattle are the factors contributing to the growth of the beta-agonist feed additives market. The growing use of beta-agonist feed additives is a result of both rising consumer health concerns and increasing technological developments aimed at improving cattle production.

Global Beta Agonist Feed Additives Market: Segments

The Ractopamine segment is expected to grow with the highest CAGR during 2022-32

Based on Product Type, the Global Beta Agonist Feed Additives Market is fragmented into Zilpaterol and Ractopamine. The Ractopamine segment is anticipated to hold the larger market share during the projection period owing to many advantages of the product. The growth of lean muscle is known to be aided by ractopamine. It works better than zilpaterol and enables livestock to grow quickly while using less feed. As a result, the cattle produce more lean meat, which is predicted to fuel the segment's expansion throughout the projection year.

The Cattle segment is expected to grow with the highest CAGR during 2022-32

Global Beta Agonist Feed Additives Market is classified on the basis of Animal Type into Cattle, Sheep, Swine, Buffalo, and Others. Over the projected period, the Cattle section is anticipated to expand significantly.  Mounting meat consumption is anticipated to increase cattle output, which might support the US beta-agonist feed additives market throughout the projected period. Feed efficiency is increased when cattle feeders use feed additives like Zilmax to accelerate weight gain without increasing feed intake.

Market Dynamics

Growth Drivers

The Growing Need to Meet the Demand for High-Value Protein and Meat Is Driving the Market

The livestock industry is increasingly demanding high-quality protein and meat. Global livestock output has significantly increased due to the urbanization, growing income in the developing economies, and increasing population worldwide. The consumption of animal protein and income is directly associated with the intake of milk, eggs, and meat. Owing to falling prices of meat and meat food products, the developing economies are preferring meat in large quantities in comparison to the developed economies couple of years back. As compared to the rural regions, urbanization has majorly fueled the demand for dairy products and meat in the cities.

The Increasing Focus of the Livestock Sector on Animal Health Is Driving The Advent Of New Additives In The Market

The market has seen the appearance of new beta agonist feed additives as a result of the organized livestock industry's greater attention to animal health. Moreover, it is anticipated that during the forecast period, rising consumer demand for higher-quality animal meat will propel market expansion.

Restraint

Less production quantity of Zilmax is hampering the market growth

Merck Animal Health stopped producing Zilmax, due to which the largest meat producer, Tyson Foods stopped buying the drug. Hence, less production quantity and less Zilmax’s use is negatively impacting the market growth.

Global Beta Agonist Feed Additives Market: Key Players

  • Elanco Animal Health
  • Quality Liquid Feeds
  • Zoetis
  • Intervet Inc. (Merck & Co. Inc.)
  • ForFarmers
  • De Heus Animal Nutrition
  • Cargill Incorporated
  • Heer Pharma Private Limited
  • HIPRA
  • Norbrook
  • Indian Immunologicals
  • Virbac
  • Biological E
  • Vetoquinol
  • Huvepharma
  • Other Prominent Players

Global Beta Agonist Feed Additives Market: Regions

Global Beta Agonist Feed Additives Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is anticipated to dominate the industry owing to the presence of significant animal meat producers and the health issues linked to a healthy diet. It is also expected that rising meat consumption will promote market expansion. Due to expanding cow feed output and rising consumer demand for meat and dairy products, the Asia Pacific market is predicted to experience significant expansion. Furthermore, it is predicted that the market would increase during the forecast period due to the existence of a sizable population in leading economies like India, China, and Japan as well as the rise of significant competitors in the industry.

Impact of COVID-19 on Beta Agonist Feed Additives Market

The supply chain of the raw material has been disrupted by the pandemic and lockdown, which have changed global patterns of consumption and manufacturing. Since animals cannot acquire enough nourishment from regular feed, vitamins, fatty acids, amino acids, and trace minerals are added to their usual diet as feed additives. The pandemic has hampered feed production, disrupted the supply chain, negatively impacted feed vendors' finances, and lowered demand for meat products, all of which have an overall negative influence on animal nutrition.

Global Beta Agonist Feed Additives Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of Asia Pacific
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of Middle East and Africa

Global Beta Agonist Feed Additives Market report also contains analysis on:

Beta Agonist Feed Additives Market Segments:

  • By Product Type
    • Zilpaterol
    • Ractopamine 
  • By Animal Type
    • Cattle
    • Sheep
    • Swine
    • Buffalo
    • Others
  • By End Users
    • Home
    • Barns
    • Hoggery
    • Other 
  • Beta Agonist Feed Additives Market Dynamics
  • Beta Agonist Feed Additives Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Beta Agonist Feed Additives Market Report Scope and Segmentation

Report Attribute Details
Market size value in 2021 USD 83.5 Billion
Revenue forecast in 2032 USD 124.2 Billion
Growth Rate CAGR of 3.7% from 2021 to 2032
Base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2032
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product Type, Animal Type, End Users, and  Region
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled Elanco Animal Health, Quality Liquid Feeds, Zoetis, Intervet Inc. (Merck & Co. Inc.), ForFarmers, De Heus Animal Nutrition, Cargill Incorporated, Heer Pharma Private Limited, HIPRA, Norbrook, Indian Immunologicals, Virbac, Biological E, Vetoquinol, Huvepharma, and Other Prominent Players.

Frequently Asked Questions (FAQ):

Beta Agonist Feed Additives Market size was estimated at USD 83.5 billion in 2021 and is expected to reach USD 124.2 billion by the end of 2032.

Beta-agonists are a family of non-hormonal substances, fed to the cattle. To reroute and slow down the metabolism of fat, they bind to receptors on the animal's fat cells.

The Ractopamine and Cattle segments accounted for the largest Beta Agonist Feed Additives Market share.

Key players in the Beta Agonist Feed Additives Market include Elanco Animal Health, Quality Liquid Feeds, Zoetis, Intervet Inc. (Merck & Co. Inc.), ForFarmers, De Heus Animal Nutrition, Cargill Incorporated, Heer Pharma Private Limited, HIPRA, Norbrook, Indian Immunologicals, Virbac, Biological E, Vetoquinol, Huvepharma, and Other Prominent Players.

The market's expansion can be ascribed to the increased per-person consumption of animal meat around the world as well as the expanding use of beta agonist feed to produce cattle.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients